Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2007 Dec;56(12):1743-6.
doi: 10.1136/gut.2006.099226. Epub 2007 Jul 12.

The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids

E H Forrest  1 , A J Morris, S Stewart, M Phillips, Y H Oo, N C Fisher, G Haydon, J O'Grady, C P Day
Affiliations
Multicenter Study

The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids

E H Forrest et al. Gut. 2007 Dec.

Abstract

Introduction: There is no consensus on the pharmacological treatment of alcoholic hepatitis. The Glasgow alcoholic hepatitis score (GAHS) has been shown to be more accurate than the modified Maddrey's discriminant function (mDF) in the prediction of outcome from alcoholic hepatitis. This study aimed to determine whether the GAHS was able to identify those patients who would benefit from corticosteroids.

Methods: 225 patients with an mDF greater than or equal to 32 from five hospital centres in the United Kingdom were reviewed. Patient survival relative to the GAHS and the use of corticosteroids was recorded.

Results: 144 patients with an mDF greater than or equal to 32 (64%) also had a GAHS greater than or equal to 9. There was no difference in survival between untreated or corticosteroid-treated patients for those with a GAHS less than 9. For patients with a GAHS greater than or equal to 9 the 28-day survival for untreated and corticosteroid-treated patients was 52% and 78% (p = 0.002), and 84-day survival was 38% and 59% (p = 0.02), respectively.

Conclusions: Among patients with an mDF greater than or equal to 32, there was no appreciable benefit from treatment with corticosteroids in patients with a GAHS less than 9. Patients with a GAHS greater than or equal to 9 have an extremely poor prognosis if they are not treated with corticosteroids, or if such treatment is contraindicated.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

References

    1. Carithers J R L, Herlong H F, Diehl A M.et al Methylprednisolone therapy in patients with severe alcoholic hepatitis: a randomized multicenter trial. Ann Intern Med 198911085–690. - PubMed
    1. Forrest E H, Evans C D J, Stewart S.et al Analysis of factors related to mortality in alcoholic hepatitis and the derivation and validation of the Glasgow alcoholic hepatitis score. Gut 2005541174–1179. - PMC - PubMed
    1. Morgan M. The treatment of alcoholic hepatitis. Alc Alcoholism 199631117–134. - PubMed
    1. Christensen E. Alcoholic hepatitis – glucocorticoids or not? J Hepatol 200236547–548. - PubMed
    1. Mathurin P, Mendenhall C L, Carithers J.et al Corticosteroids improve short‐term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 200236480–487. - PubMed

Substances